|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||114.53 / 199.43|
Here is what you need to know.
Generic drugmakers are likely to limit themselves to acquisitions of small- and mid-sized companies in the immediate future because of over-leveraging and turmoil in the executive ranks..
The most recent short interest data has been released for the 05/31/2017 settlement date, which shows a 874,390 share decrease in total short interest for McKesson Corp , to 3,950,969, a decrease of 18.12% since 05/15/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.
Watch those valuations.
Walmart retains the top spot for the fifth straight year with 2016 revenues totaling $485.9 billion.
Here are Tuesday's top research calls, including downgrades for Ambarella and BlackBerry, and upgrades for PVH Corp. and Zynga.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: MCK, MRVL, NSH, TEF Downgrades: ANW, BOSC, FET, GPX, MIXT, UAN Initiations: None Read on to get TheStreet Quant Ratings' detailed report:
McKesson Corporation (NYSE:MCK) today announced that James Beer, executive vice president and chief financial officer, will present at the Goldman Sachs 38 th Annual Global Healthcare Conference in Rancho Palos Verdes at...
The Board of Directors of McKesson Corporation (NYSE:MCK) today declared a regular dividend of twenty-eight cents per share on Common Stock.
The firm's analyst believes additional value should be unlocked from the Change transaction and that the valuation discount versus peers is unwarranted.
Here are Tuesday's top research calls, including new coverage of recent IPOs Cloudera and Carvana, as well as new analyst coverage of Domino's Pizza and an upgrade of McKesson.
Ahead of Fed's June meeting, investors will need to start paying close attention to Fed officials and economic data.
Jim Cramer discusses the rebound and also mentions the best tech story that no one knows about.
The drug distributor reported better-than-expected adjusted EPS for the fourth quarter of fiscal 2017.
McKesson Corporation (NYSE:MCK) today reported that revenues for the fourth quarter ended March 31, 2017, were $48.
Of firms that reported, 75% beat expectations for earnings per share, while 64% beat revenue projections.
The drug distributor is scheduled to report quarterly results after the market close on Thursday.
Concert must submit toxicology data to the FDA before proceeding with Phase 2 trials.
Here are Wednesday's top research calls, including new coverage of Advanced Micro Devices and Transocean, upgrades for Clovis Oncology and ConocoPhillips, and a downgrade for Disney.
While hard at work in Washington, a handful of members of Congress have also been busy trading stocks.
McKesson Corporation (NYSE:MCK) will release financial results for its fourth fiscal quarter ended March 31, 2017 on Thursday, May 18, 2017, following the market close at approximately 4:00 PM Eastern Time (1:00 PM Pacific...
McKesson Corporation (NYSE:MCK), a global leader in healthcare supply chain management solutions, announced today that it has completed the previously announced acquisition of CoverMyMeds LLC.
McKesson Corporation (NYSE:MCK), a leading global healthcare services and information technology company, and Change Healthcare Holdings, Inc.